⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18975990 | 0.84 | — | — | |
| SCHEMBL20121060 | 0.75 | — | — | |
| SCHEMBL18960695 | 0.75 | — | — | |
| SCHEMBL20121062 | 0.72 | — | — | |
| SCHEMBL20121061 | 0.72 | — | — | |
| SCHEMBL23435718 | 0.72 | CYP1A2 (0.41) | — | |
| SCHEMBL18969300 | 0.71 | — | — | |
| SCHEMBL25859517 | 0.69 | — | — | |
| SCHEMBL18969306 | 0.69 | — | — | |
| SCHEMBL18969305 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963448-B2 | Bicyclic inhibitors of PAD4 | PADLOCK THERAPEUTICS, INC. (US) | 2018-05-08 | — | — | US | disclosed |
| US-20170166565-A1 | BICYCLIC INHIBITORS OF PAD4 | PADLOCK THERAPEUTICS, INC. | 2017-06-15 | — | — | US | disclosed |